Latest On AVDR US LargeCap Leading ETF (AVDR):
About AVDR US LargeCap Leading ETF (AVDR):
New Age Alpha Trust - AVDR US LargeCap Leading ETF is an exchange traded fund launched and managed by New Age Alpha Advisors, LLC. It is co-managed by Vident Investment Advisory, LLC. The fund invests in the public equity markets of the United States. It invests in stocks of companies operating across diversified sector. The fund primarily invests in growth and value stocks of large-cap companies. It seeks to track the performance of the New Age Alpha U.S. Large-Cap Leading 50 Index, by investing in stocks as per their weightings in the index. The fund employs proprietary research to create its portfolio. New Age Alpha Trust - AVDR US LargeCap Leading ETF is domiciled in the United States.
General
- Name AVDR US LargeCap Leading ETF
- Symbol AVDR
- Type Common Stock
- Exchange BATS
- Currency USD
- Country USA
- SectorOther
- IndustryOther
- Fiscal Year EndDecember
- Web URLavedro.com
Financials
- Most Recent Quarter 2019-09-30
- Next Quarter EPS Estimate -$0.44
- Earnings Per Share -$3.92
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
Highlights
- Market Capitalization 402.8 million
- EBITDA -24000000
- Analyst Target Price $24.33
- Book Value Per Share $2.52
Share Statistics
- % Held by Insiders <1%
Technicals
- 52 Week High $26.22
- 52 Week Low $24.92
- 50 Day Moving Average 25.69
- 200 Day Moving Average 25.69
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0.85%
AVDR US LargeCap Leading ETF (AVDR) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
AVDR US LargeCap Leading ETF (AVDR) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2018-12-31 | 2019-03-22 | $8.21 million | -$4.59 | -$0.50 | -818% |
AVDR US LargeCap Leading ETF (AVDR) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 | Sep 30 2018 |
---|---|---|---|---|---|
Research Development | 3.81 million | 3.9 million | 4.29 million | 3.22 million | N/A |
Income Before Tax | -9.07 million | -7.43 million | -8.35 million | -6.41 million | N/A |
Selling General Administrative | 10.17 million | 10.47 million | 10.22 million | 7 million | N/A |
Gross Profit | 8.64 million | 7.51 million | 6.49 million | 5.55 million | N/A |
Ebit | -5.33 million | -6.86 million | -8.02 million | -4.67 million | N/A |
Operating Income | -5.33 million | -6.86 million | -8.02 million | -4.67 million | N/A |
Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
Total Revenue | 11.05 million | 10.29 million | 8.77 million | 8.21 million | N/A |
Cost of Revenue | 2.4 million | 2.78 million | 2.28 million | 2.66 million | N/A |
Total Other Income Expense Net | -3.73 million | -568000 | -336000 | -1.74 million | N/A |
Net Income From Continuing Operations | -9.07 million | -7.43 million | -8.35 million | -6.41 million | N/A |
Net Income Applicable to Common Shares | -9.07 million | -7.43 million | -8.35 million | -6.41 million | N/A |
Cash Flow:
Date | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 | Sep 30 2018 |
---|---|---|---|---|---|
Investments | N/A | N/A | N/A | N/A | N/A |
Change to Liabilities | 838000 | 784000 | 329000 | -1.72 million | 1.46 million |
Total Cash Flow from Investing Activities | -182000 | -91000 | -80000 | -105000 | N/A |
Net Borrowings | -9000 | -9000 | -10000 | -10000 | N/A |
Total Cash Flow from Financial Activities | 398000 | -1.6 million | 63.67 million | -1.26 million | 24.72 million |
Change to Operating Activities | -793000 | 785000 | -971000 | -190000 | N/A |
Change in Cash | -5.69 million | -6.97 million | 55.04 million | -7.16 million | N/A |
Total Cash from Operating Activities | -5.91 million | -5.28 million | -8.55 million | -5.8 million | N/A |
Depreciation | 193000 | 169000 | 174000 | 177000 | N/A |
Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
Change to Inventory | 249000 | -432000 | -224000 | 942000 | N/A |
Change to Account Receivables | -713000 | -609000 | -752000 | -169000 | N/A |
Other Cash Flow from Financing Activities | N/A | -1.7 million | -1.43 million | -1.26 million | N/A |
Change to Net Income | 3.38 million | 1.45 million | 1.25 million | 1.58 million | N/A |
Capital Expenditures | 182000 | 91000 | 80000 | 105000 | 256000 |
Balance Sheet:
Date | Sep 30 2019 | Jun 30 2019 | Mar 31 2019 | Dec 31 2018 | Sep 30 2018 |
---|---|---|---|---|---|
Total Liabailities | 30.44 million | 28.91 million | 29.48 million | 29.23 million | 30.14 million |
Total Stockholder Equity | 44.1 million | 50.04 million | 56.27 million | -73.59 million | 1.02 million |
Other Current Liabilities | 911000 | 898000 | 1.15 million | 1.1 million | 7.52 million |
Total Assets | 74.53 million | 78.95 million | 85.75 million | 25.87 million | 31.16 million |
Common Stock | 2000 | 2000 | 2000 | 2000 | 2000 |
Other Current Assets | 769000 | 279000 | 449000 | 503000 | 1.76 million |
Retained Earnings | -201.3 million | -192.23 million | -184.8 million | -182.12 million | N/A |
Other Liabilities | 458000 | 458000 | 468000 | 457000 | 1.59 million |
Other Assets | 769000 | 873000 | 931000 | 3.67 million | 915000 |
Cash | 52.15 million | 57.84 million | 64.81 million | 9.77 million | 16.93 million |
Total Current Liabilities | 8.59 million | 7.75 million | 8.68 million | 8.43 million | 8.79 million |
Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
Property, Plant & Equipment | 1.54 million | 1.35 million | 1.45 million | 1.52 million | 1.62 million |
Total Current Assets | 72.22 million | 76.73 million | 83.37 million | 20.67 million | N/A |
Long Term Investments | N/A | N/A | N/A | N/A | N/A |
Net Tangible Assets | 44.1 million | 50.04 million | 56.27 million | -73.59 million | N/A |
Short Term Investments | N/A | N/A | N/A | N/A | N/A |
Long Term Debt | 21.39 million | 20.71 million | 20.33 million | 20.35 million | 19.77 million |
Inventory | 4.48 million | 4.92 million | 4.47 million | 4.26 million | 5.31 million |
Accounts Payable | 1.48 million | 1.97 million | 2.52 million | 2.13 million | 1.27 million |
AVDR US LargeCap Leading ETF (AVDR) Chart:
AVDR US LargeCap Leading ETF (AVDR) News:
Below you will find a list of latest news for AVDR US LargeCap Leading ETF (AVDR) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
AVDR US LargeCap Leading ETF (AVDR) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
AVDR US LargeCap Leading ETF (AVDR) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2019-12-02 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1343304/000119312519303673/0001193125-19-303673-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000089924319028099/0000899243-19-028099-index.htm |
2019-09-09 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1343304/000094787119000664/0000947871-19-000664-index.htm |
2019-10-17 | DEFM14A | Definitive proxy statement relating to merger or acquisition | https://www.sec.gov/Archives/edgar/data/1343304/000104746919005789/0001047469-19-005789-index.htm |
2019-08-13 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1343304/000110465919045378/0001104659-19-045378-index.htm |
2019-09-05 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1343304/000110465919048923/0001104659-19-048923-index.htm |
2019-11-07 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1343304/000110465919060728/0001104659-19-060728-index.htm |
2019-11-14 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1343304/000110465919064341/0001104659-19-064341-index.htm |
2019-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1343304/000119312519285390/0001193125-19-285390-index.htm |
2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1343304/000119312519288431/0001193125-19-288431-index.htm |
2019-11-08 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1343304/000119312519288432/0001193125-19-288432-index.htm |
2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1343304/000119312519293849/0001193125-19-293849-index.htm |
2019-11-18 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1343304/000119312519293850/0001193125-19-293850-index.htm |
2019-11-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1343304/000119312519297100/0001193125-19-297100-index.htm |
2019-11-21 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments | https://www.sec.gov/Archives/edgar/data/1343304/000119312519297103/0001193125-19-297103-index.htm |
2019-12-02 | 15-12B | Securities registration termination [Section 12(b)] | https://www.sec.gov/Archives/edgar/data/1343304/000119312519303673/0001193125-19-303673-index.htm |
2019-08-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119045346/0001209191-19-045346-index.htm |
2019-09-05 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048626/0001209191-19-048626-index.htm |
2019-09-05 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048627/0001209191-19-048627-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048628/0001209191-19-048628-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048629/0001209191-19-048629-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048630/0001209191-19-048630-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048631/0001209191-19-048631-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048634/0001209191-19-048634-index.htm |
2019-09-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048637/0001209191-19-048637-index.htm |
2019-11-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057028/0001209191-19-057028-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057926/0001209191-19-057926-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057927/0001209191-19-057927-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057929/0001209191-19-057929-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057938/0001209191-19-057938-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057939/0001209191-19-057939-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057941/0001209191-19-057941-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057943/0001209191-19-057943-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057945/0001209191-19-057945-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057946/0001209191-19-057946-index.htm |
2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057947/0001209191-19-057947-index.htm |
2019-11-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1343304/000120919119058121/0001209191-19-058121-index.htm |
2019-09-12 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1343304/000121390019017888/0001213900-19-017888-index.htm |
2019-11-21 | 25-NSE | Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or ret | https://www.sec.gov/Archives/edgar/data/1343304/000135445719000614/0001354457-19-000614-index.htm |
2019-11-07 | 425 | Prospectuses and communications, business combinations | https://www.sec.gov/Archives/edgar/data/1343304/000155837019010227/0001558370-19-010227-index.htm |
2019-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1343304/000156459019040705/0001564590-19-040705-index.htm |
AVDR US LargeCap Leading ETF (AVDR) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of AVDR US LargeCap Leading ETF (AVDR). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: < 1%Institutional Ownership: < 1%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2019-11-21 | David First | Chief Human Resources Officer | Sell | 2,254.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057927/0001209191-19-057927-index.htm | ||
2019-11-21 | Donald Zurbay | Director | Sell | 3,500.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057947/0001209191-19-057947-index.htm | ||
2019-11-21 | Garheng Kong | Director | Sell | 1,437,096.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119058121/0001209191-19-058121-index.htm | ||
2019-11-21 | James Schuermann | Chief Business Officer | Sell | 942.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057943/0001209191-19-057943-index.htm | ||
2019-11-21 | JONATHAN SILVERSTEIN | Director | Sell | 4,240,128.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057945/0001209191-19-057945-index.htm | ||
2019-11-21 | Paul S Bavier | General Counsel and Sec. | Sell | 606.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057926/0001209191-19-057926-index.htm | ||
2019-11-21 | Rajesh K. Rajpal | Chief Medical Officer | Sell | 127,666.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057941/0001209191-19-057941-index.htm | ||
2019-11-21 | Reza Zadno | President and CEO | Sell | 18,062.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057946/0001209191-19-057946-index.htm | ||
2019-11-21 | ROBERT J PALMISANO | Director | Sell | 37,733.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057939/0001209191-19-057939-index.htm | ||
2019-11-21 | THOMAS E GRIFFIN | Chief Financial Officer | Sell | 12,507.00 | 0.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057929/0001209191-19-057929-index.htm | ||
2019-08-07 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 44,703.00 | 2.14 | 95,664.42 | 107,279.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119045346/0001209191-19-045346-index.htm |
2019-03-01 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 106.00 | 115,500.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048631/0001209191-19-048631-index.htm | ||
2019-08-07 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 8,279.00 | 3.69 | 30,549.51 | 115,558.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119045346/0001209191-19-045346-index.htm |
2019-06-03 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 106.00 | 115,606.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048631/0001209191-19-048631-index.htm | ||
2019-08-07 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 367.00 | 12.73 | 4,671.91 | 115,925.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119045346/0001209191-19-045346-index.htm |
2019-09-03 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 1,049.00 | 116,655.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048631/0001209191-19-048631-index.htm | ||
2019-11-14 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 3,321.00 | 1.34 | 4,450.14 | 119,976.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057028/0001209191-19-057028-index.htm |
2019-11-14 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 1,558.00 | 2.14 | 3,334.12 | 121,534.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057028/0001209191-19-057028-index.htm |
2019-09-03 | THOMAS E GRIFFIN | Chief Financial Officer | Buy | 1,007.00 | 12,507.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048630/0001209191-19-048630-index.htm | ||
2019-11-14 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 4,221.00 | 2.14 | 9,032.94 | 125,755.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057028/0001209191-19-057028-index.htm |
2019-03-01 | Reza Zadno | President and CEO | Buy | 1,052.00 | 12,617.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048637/0001209191-19-048637-index.htm | ||
2019-11-14 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 1,911.00 | 3.69 | 7,051.59 | 127,666.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119057028/0001209191-19-057028-index.htm |
2019-06-03 | Reza Zadno | President and CEO | Buy | 1,051.00 | 13,668.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048637/0001209191-19-048637-index.htm | ||
2019-09-03 | Reza Zadno | President and CEO | Buy | 6,147.00 | 19,815.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048637/0001209191-19-048637-index.htm | ||
2019-09-03 | David First | Chief Human Resources Officer | Buy | 754.00 | 2,254.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048629/0001209191-19-048629-index.htm | ||
2019-08-07 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 44,290.00 | 1.34 | 59,348.60 | 53,233.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119045346/0001209191-19-045346-index.htm |
2019-08-07 | Rajesh K. Rajpal | Chief Medical Officer | Buy | 9,343.00 | 2.14 | 19,994.02 | 62,576.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119045346/0001209191-19-045346-index.htm |
2019-09-03 | Paul S Bavier | General Counsel and Sec. | Buy | 848.00 | 848.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048628/0001209191-19-048628-index.htm | ||
2019-09-03 | James Schuermann | Chief Business Officer | Buy | 942.00 | 942.00 | https://www.sec.gov/Archives/edgar/data/1343304/000120919119048634/0001209191-19-048634-index.htm |